Dimethyl fumarate (DMF), an approved drug for the treatment of multiple sclerosis, activates the Nrf2 pathway showing a protective effect against α-synucleinopathy toxicity in the murine model of PD [20]. The gene discussed is NFE2L2; the disease is synucleinopathy.